Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4227601

Cc1ccc2c(c1)CCCN2C(=O)CNCc1ccc(Cl)c(Cl)c1.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.46
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
IDO1 P14902 2/20 0.43
KCNH2 Q12809 2/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HTT P42858 2/20 0.42
ALDH1A1 P00352 4/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 1/20 0.40
TSHR P16473 2/20 0.40
PARP1 P09874 1/20 0.40
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
CHRM2 P08172 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4233181 0.79 GRM7 (0.50) KDM4EMEN1KMT2AHTTALDH1A1
Trifluoroacetic Acid SCHEMBL4370952 0.76 GRM7 (0.67) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL15703719 0.74 DRD2 (0.60) DRD2DRD4MEN1KMT2AALDH1A1
Trifluoroacetic Acid SCHEMBL4232671 0.71 POLB (0.44) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL22525270 0.71 KDM4E (0.64) KDM4EDRD2DRD4MEN1KMT2A
Trifluoroacetic Acid SCHEMBL4375076 0.70 GRM7 (0.52) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL11710635 0.69 KDM4E (0.66) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL13525164 0.69 KDM4E (0.66) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL4026091 0.68 KDM4E (0.71) KDM4EMEN1KMT2AHTTALDH1A1
Trifluoroacetic Acid SCHEMBL6257839 0.67 TSHR (0.54) KDM4EMEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096104-A1 Organic diamines as mGluR7 modulators Novartis AG (CH) 2009-09-02 EP disclosed
US-20080242698-A1 Organic Compounds NOVARTIS AG (CH) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242698-A1 Organic Compounds AOC1, OTC, ODC1 KDM4E 2294/4885DRD2 252/4885DRD4 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.